National Chapters
ISoP members in one country are able to form groups to facilitate the organisation of meetings, training courses, or other activities related to the missions of ISoP.
A national chapter has been already developed in Italy, Western Pacific region, Mexico, latin America and Switzerland.
Click here for the Chapters guidelines
or you can contact ISoP Administration for more information.
The swiss chapter of ISoP
Welcome to the ISoP Swiss Chapter!
The creation of the ISoP Swiss Chapter was officially announced in October 2009 at the Annual Meeting in Reims (France).
The Western Pacific Chapter of ISoP
At the Annual Meeting in Liege in October 2006, a group from New Zealand, Philippines and Australia discussed the possibility of establishing a regional Chapter of ISoP. Chapters are locally established sub-groups of the Society which are intended to actively address the needs arising from a range of pharmacovigilance activities in their respective countries. One important aim is to enable ISoP members to be personally involved in the future of pharmacovigilance in their region.
Following on from these initial discussions, it was decided that the new Chapter of ISoP should include members in the countries in the WHO Western Pacific region (as shown in Table 1).
Table 1: Countries included in the WHO Western Pacific Region
| American Samoa |
Nauru |
| * Australia |
New Caledonia |
| Brunei Darussalam |
* New Zealand |
| Cambodia |
Niue |
| * China |
Northern Mariana Islands |
| Cook Islands |
Palau |
| Fiji |
Papua New Guinea |
| French Polynesia |
* Philippines |
| Guam |
Pitcairn Islands |
| Hong Kong ( China ) |
Samoa |
| * Japan |
Singapore |
| Kiribati |
Solomon Islands |
| * Korea , Republic of |
Tokelau |
| Lao People's Democratic Republic |
Tonga |
| Macao ( China ) |
Tuvalu |
| * Malaysia |
Vanuatu |
| Marshall Islands |
Viet Nam |
| Micronesia , Federated States of |
Wallis and Futuna |
* Countries with current ISoP members
ISoP members in Taiwan and Thailand have also been included in the Western Pacific Chapter. There are currently no other ISoP members in countries in the South East Asia WHO region.
The first Coordinator of the Western Pacific Chapter will be Dr Mira Harrison-Woolrych who is the Director of the New Zealand Intensive Medicines Monitoring Programme (IMMP). Dr Suzette Lazo - former President of the Philippine Society of Experimental and Clinical Pharmacology and a member of the ISoP committee on elections 2006 - has agreed to act as Secretary of the new Chapter. Drs Harrison-Woolrych and Lazo are very enthusiastic about the formation of the new Chapter and are encouraging all those with a keen interest in pharmacovigilance in the Western Pacific region to consider joining ISoP and participate in activities in this region.
The Western Pacific Chapter will be launched at the annual ISoP meeting in Bournemouth, UK in October 2007. There will be a specific session about pharmacovigilance in the Western Pacific region and those interested are encouraged to attend. ISoP are also planning a pharmacovigilance course in Bangkok in March 2008. The final details should be available at the ISoP annual meeting in Bournemouth.
Anyone interested in joining the Western Pacific Chapter is invited to contact ISoP Administration.
 Mira Harrison-Woolrych, Coordinator of the Western Pacific Chapter, during the 7th ISoP Annual Meeting
|
